MetaADEDB 2.0 @ LMMD
Dexlansoprazole
(MJIHNNLFOKEZEW-RUZDIDTESA-N)
Structure
SMILES
O=[S@@](c1nc2c([nH]1)cccc2)Cc1nccc(c1C)OCC(F)(F)F
Type(s)
Approved; Investigational
ATC code(s)
A02BC06
Molecular Formula:
C16H14F3N3O2S
Molecular Weight:
369.361
Log P:
4.3809
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
87.08
CAS Number(s):
138530-94-6
Synonym(s)
1.
Dexlansoprazole
2.
2-((R)-((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
3.
Dexilant
4.
Dexlansoprazole Sesquihydrate
5.
Lansoprazole, R-Isomer
6.
R-Lansoprazole
7.
T-168390
8.
TAK 390MR
9.
TAK-390
10.
TAK-390MR
11.
TAK390MR
12.
Lansoprazole, R Isomer
13.
R Lansoprazole
14.
R-Isomer Lansoprazole
15.
T 168390
16.
T168390
17.
TAK 390
18.
TAK390
External Link(s)
MeSHD064748
PubChem Compound9578005
BindingDB50247930
ChEBI135931
CHEMBLCHEMBL1201863
DrugBankDB05351
DrugCentral4162
IUPHAR/BPS Guide to PHARMACOLOGY5487
KEGGdr:D08903
Therapeutic Target DatabaseD06YYD
ZINC599734
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1No adverse eventFAERS: 86US FAERS
2Drug ineffectiveFAERS: 77
Canada Vigilance: 17
Canada Vigilance
US FAERS
3NauseaFAERS: 66
Canada Vigilance: 5
Canada Vigilance
US FAERS
4DizzinessFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
5HeadacheFAERS: 49
Canada Vigilance: 4
Canada Vigilance
US FAERS
6Incorrect drug administration durationFAERS: 46US FAERS
7VomitingFAERS: 42
Canada Vigilance: 4
Canada Vigilance
US FAERS
8Abdominal PainFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
9UrticariaFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
10PruritusFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
11FlatulenceFAERS: 28US FAERS
12AstheniaFAERS: 26US FAERS
13Chest PainFAERS: 26US FAERS
14ArthralgiaFAERS: 25
Canada Vigilance: 3
Canada Vigilance
US FAERS
15ConstipationFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
16FatigueFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
17Feeling abnormalFAERS: 20
Canada Vigilance: 3
Canada Vigilance
US FAERS
18PainFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
19PalpitationsFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
20Acute kidney injuryFAERS: 19US FAERS
21HypersensitivityFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
22OverdoseFAERS: 16US FAERS
23Abdominal discomfortFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
24AnxietyFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
25ChillsFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
26MalaiseFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
27MyalgiaFAERS: 15
Canada Vigilance: 3
Canada Vigilance
US FAERS
28Oropharyngeal painFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
29DyspepsiaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
30NasopharyngitisFAERS: 14US FAERS
31TremorFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Adverse eventFAERS: 13US FAERS
33Chest discomfortFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
34Drug prescribing errorFAERS: 12US FAERS
35Weight decreasedFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
36Anaphylactic shockFAERS: 11US FAERS
37Lip swellingFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
38TinnitusFAERS: 11US FAERS
39Back PainFAERS: 10US FAERS
40DehydrationFAERS: 9
Canada Vigilance: 6
Canada Vigilance
US FAERS
41DysphoniaFAERS: 9US FAERS
42HypotensionFAERS: 9US FAERS
43Inappropriate schedule of drug administrationFAERS: 9US FAERS
44SwellingFAERS: 9US FAERS
45Wrong technique in product usage processFAERS: 9US FAERS
46AlopeciaFAERS: 8US FAERS
47Atrial FibrillationFAERS: 8US FAERS
48DysgeusiaFAERS: 8US FAERS
49SyncopeFAERS: 8US FAERS
50VertigoFAERS: 8US FAERS
51Incorrect product administration durationFAERS: 7US FAERS
52PneumoniaFAERS: 7US FAERS
53Prescribed overdoseFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Product use issueFAERS: 7US FAERS
55TachycardiaFAERS: 7US FAERS
56Visual ImpairmentFAERS: 7US FAERS
57Neck PainFAERS: 6US FAERS
58WheezingFAERS: 6US FAERS
59AbasiaFAERS: 5US FAERS
60Blood glucose increasedFAERS: 5US FAERS
61Bone painFAERS: 5US FAERS
62Burning sensationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
63ErythemaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
64FlushingFAERS: 5US FAERS
65Joint swellingFAERS: 5US FAERS
66Rebound acid hypersecretionFAERS: 5US FAERS
67StomatitisFAERS: 5US FAERS
68Throat irritationFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
69Accidental overdoseFAERS: 4US FAERS
70AmnesiaFAERS: 4US FAERS
71Cerebrovascular accidentFAERS: 4US FAERS
72CholelithiasisFAERS: 4US FAERS
73ColitisFAERS: 4US FAERS
74Drug dose omissionFAERS: 4US FAERS
75EructationFAERS: 4US FAERS
76GastritisFAERS: 4US FAERS
77Memory impairmentFAERS: 4US FAERS
78Musculoskeletal PainFAERS: 4US FAERS
79Productive CoughFAERS: 4US FAERS
80SomnolenceFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
81ArthropathyFAERS: 3US FAERS
82Blood magnesium decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
83ChromaturiaFAERS: 3US FAERS
84Clostridium difficile infectionFAERS: 3US FAERS
85DeafnessFAERS: 3US FAERS
86Drug dispensing errorFAERS: 3US FAERS
87Dry skinFAERS: 3US FAERS
88Gastrointestinal PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Myocardial InfarctionFAERS: 3US FAERS
90Oral painFAERS: 3US FAERS
91Oropharyngeal discomfortFAERS: 3US FAERS
92Peripheral swellingFAERS: 3US FAERS
93Poor quality product administeredFAERS: 3US FAERS
94Throat cancerFAERS: 3US FAERS
95Accidental exposure to product by childFAERS: 2US FAERS
96AcneFAERS: 2US FAERS
97AngioedemaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Ankle FractureFAERS: 2US FAERS
99AphoniaFAERS: 2US FAERS
100Apparent deathFAERS: 2US FAERS
101AsthmaFAERS: 2US FAERS
102Blood creatinine increasedFAERS: 2US FAERS
103Blood potassium decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
104Blood urine presentFAERS: 2US FAERS
105BradycardiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
106BronchospasmFAERS: 2US FAERS
107Cardiac ArrestFAERS: 2US FAERS
108Deep Vein ThrombosisFAERS: 2US FAERS
109Device related infectionFAERS: 2US FAERS
110DiscomfortFAERS: 2US FAERS
111DysuriaFAERS: 2US FAERS
112Ear discomfortFAERS: 2US FAERS
113Electrolyte imbalanceFAERS: 2US FAERS
114Eye painFAERS: 2US FAERS
115Feeling jitteryFAERS: 2US FAERS
116Gastric infectionFAERS: 2US FAERS
117GlossitisFAERS: 2US FAERS
118HepatitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
119HypophagiaFAERS: 2US FAERS
120Impaired gastric emptyingFAERS: 2US FAERS
121Impaired work abilityFAERS: 2US FAERS
122Incorrect dose administeredFAERS: 2US FAERS
123Iron deficiencyFAERS: 2US FAERS
124Irritable Bowel SyndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Joint stiffnessFAERS: 2US FAERS
126LethargyFAERS: 2US FAERS
127LeukopeniaFAERS: 2US FAERS
128Magnesium DeficiencyFAERS: 2US FAERS
129Middle insomniaFAERS: 2US FAERS
130Musculoskeletal stiffnessFAERS: 2US FAERS
131NephrolithiasisFAERS: 2US FAERS
132Non-cardiac chest painFAERS: 2US FAERS
133OsteoporosisFAERS: 2US FAERS
134PancreatitisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
135Pharyngeal StenosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
136Post procedural complicationFAERS: 2US FAERS
137Product quality issueFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
138Product substitution issueFAERS: 2US FAERS
139Product use in unapproved indicationFAERS: 2US FAERS
140Respiratory FailureFAERS: 2US FAERS
141Respiratory distressFAERS: 2US FAERS
142Restless Legs SyndromeFAERS: 2US FAERS
143RestlessnessFAERS: 2US FAERS
144RetchingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
145SinusitisFAERS: 2US FAERS
146Stevens-Johnson SyndromeFAERS: 2US FAERS
147StressFAERS: 2US FAERS
148Tongue discomfortFAERS: 2US FAERS
149Toxic Epidermal NecrolysisFAERS: 2US FAERS
150Unevaluable eventFAERS: 2US FAERS
151Urinary tract infectionFAERS: 2US FAERS
152Vulvovaginal mycotic infectionFAERS: 2US FAERS
153Vulvovaginal painFAERS: 2US FAERS
154Wheelchair userFAERS: 2US FAERS
155nervous system disorderFAERS: 2US FAERS
156Abdominal tendernessFAERS: 1US FAERS
157AbscessFAERS: 1US FAERS
158AgeusiaFAERS: 1US FAERS
159Alanine Aminotransferase IncreasedFAERS: 1US FAERS
160Allergic reaction to excipientFAERS: 1US FAERS
161Anal polypFAERS: 1US FAERS
162Angina PectorisFAERS: 1US FAERS
163AppendicitisFAERS: 1US FAERS
164ArthritisFAERS: 1US FAERS
165Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
166AsthenopiaFAERS: 1US FAERS
167BlepharospasmFAERS: 1US FAERS
168Blood chromogranin A increasedFAERS: 1US FAERS
169Blood creatinine abnormalFAERS: 1US FAERS
170Blood urea increasedFAERS: 1US FAERS
171Bowel movement irregularityFAERS: 1US FAERS
172BruxismFAERS: 1US FAERS
173Cancer PainFAERS: 1US FAERS
174Cardiac FlutterFAERS: 1US FAERS
175Cardiac discomfortFAERS: 1US FAERS
176Cardioactive drug level increasedFAERS: 1US FAERS
177Carpal Tunnel SyndromeFAERS: 1US FAERS
178CataractFAERS: 1US FAERS
179CheilitisFAERS: 1US FAERS
180ChokingFAERS: 1US FAERS
181Clostridium difficile colitisFAERS: 1US FAERS
182Clostridium test positiveFAERS: 1US FAERS
183Contraindicated drug administeredFAERS: 1US FAERS
184Creatinine renal clearance decreasedFAERS: 1US FAERS
185CryingFAERS: 1US FAERS
186CystitisFAERS: 1US FAERS
187DeliriumFAERS: 1US FAERS
188DermatitisFAERS: 1US FAERS
189Device occlusionFAERS: 1US FAERS
190DisabilityFAERS: 1US FAERS
191Disease recurrenceFAERS: 1US FAERS
192DroolingFAERS: 1US FAERS
193Drug DependenceFAERS: 1US FAERS
194Drug administered to patient of inappropriate ageFAERS: 1US FAERS
195Drug ineffective for unapproved indicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
196Drug screen false positiveFAERS: 1US FAERS
197Drug withdrawal syndromeFAERS: 1US FAERS
198DysarthriaFAERS: 1US FAERS
199DyslexiaFAERS: 1US FAERS
200DystoniaFAERS: 1US FAERS
201Electrocardiogram ST-T changeFAERS: 1US FAERS
202ElectrocardiogramFAERS: 1US FAERS
203Enlarged uvulaFAERS: 1US FAERS
204Erectile dysfunctionFAERS: 1US FAERS
205Expired product administeredFAERS: 1US FAERS
206Extra dose administeredFAERS: 1US FAERS
207Eye irritationFAERS: 1US FAERS
208Fallopian tube obstructionFAERS: 1US FAERS
209FormicationFAERS: 1US FAERS
210Full blood count decreasedFAERS: 1US FAERS
211Gastric BypassFAERS: 1US FAERS
212Gastric pH decreasedFAERS: 1US FAERS
213Gastrointestinal bacterial infectionFAERS: 1US FAERS
214Gastrointestinal hypomotilityFAERS: 1US FAERS
215GastrostomyFAERS: 1US FAERS
216General physical health deteriorationFAERS: 1US FAERS
217Genital rashFAERS: 1US FAERS
218Genito-pelvic pain/penetration disorderFAERS: 1US FAERS
219GliomaFAERS: 1US FAERS
220HemiparesisFAERS: 1US FAERS
221HerniaFAERS: 1US FAERS
222HistoplasmosisFAERS: 1US FAERS
223HyperchlorhydriaFAERS: 1US FAERS
224Hypertensive crisisFAERS: 1US FAERS
225HypothyroidismFAERS: 1US FAERS
226HypoxiaFAERS: 1US FAERS
227Incorrect product storageFAERS: 1US FAERS
228Increased upper airway secretionFAERS: 1US FAERS
229InfluenzaFAERS: 1US FAERS
230Intentional product use issueFAERS: 1US FAERS
231Intercepted drug prescribing errorFAERS: 1US FAERS
232Intestinal PerforationFAERS: 1US FAERS
233Intestinal resectionFAERS: 1US FAERS
234Joint Range of Motion DecreasedFAERS: 1US FAERS
235Joint injuryFAERS: 1US FAERS
236LaryngospasmFAERS: 1US FAERS
237Leukocytoclastic vasculitisFAERS: 1US FAERS
238Limb discomfortFAERS: 1US FAERS
239Lung perforationFAERS: 1US FAERS
240MalabsorptionFAERS: 1US FAERS
241Maternal exposure during pregnancyFAERS: 1US FAERS
242Medication ErrorFAERS: 1US FAERS
243Metastases to pelvisFAERS: 1US FAERS
244MiliariaFAERS: 1US FAERS
245Mood swingsFAERS: 1US FAERS
246Morbid thoughtsFAERS: 1US FAERS
247Motion SicknessFAERS: 1US FAERS
248Multiple Chemical SensitivityFAERS: 1US FAERS
249Muscle strainFAERS: 1US FAERS
250Musculoskeletal chest painFAERS: 1US FAERS
251MyositisFAERS: 1US FAERS
252NeuralgiaFAERS: 1US FAERS
253NocturiaFAERS: 1US FAERS
254Ocular discomfortFAERS: 1US FAERS
255OligohydramniosFAERS: 1US FAERS
256OnychoclasisFAERS: 1US FAERS
257Oral fungal infectionFAERS: 1US FAERS
258Oral pruritusFAERS: 1US FAERS
259OsteopeniaFAERS: 1US FAERS
260Pancreatic CystFAERS: 1US FAERS
261Pancreatic NeoplasmFAERS: 1US FAERS
262PancytopeniaFAERS: 1US FAERS
263Paranasal sinus hypersecretionFAERS: 1US FAERS
264Patient dissatisfaction with treatmentFAERS: 1US FAERS
265Perineal erythemaFAERS: 1US FAERS
266Peripheral venous diseaseFAERS: 1US FAERS
267PetechiaeFAERS: 1US FAERS
268Post procedural swellingFAERS: 1US FAERS
269Precancerous cells presentFAERS: 1US FAERS
270Prescription drug used without a prescriptionFAERS: 1US FAERS
271PresyncopeFAERS: 1US FAERS
272Procedural complicationFAERS: 1US FAERS
273Product difficult to swallowFAERS: 1US FAERS
274Product dose omissionFAERS: 1US FAERS
275Product label issueFAERS: 1US FAERS
276Product packaging issueFAERS: 1US FAERS
277Product selection errorFAERS: 1US FAERS
278Pulmonary EmbolismFAERS: 1US FAERS
279Pulmonary FibrosisFAERS: 1US FAERS
280Reaction to food additiveFAERS: 1US FAERS
281Reaction to preservativesFAERS: 1US FAERS
282Rectal fissureFAERS: 1US FAERS
283Reflux gastritisFAERS: 1US FAERS
284RegurgitationFAERS: 1US FAERS
285Renal artery stent placementFAERS: 1US FAERS
286Renal cystFAERS: 1US FAERS
287Renal painFAERS: 1US FAERS
288Respiratory arrestFAERS: 1US FAERS
289Respiratory tract congestionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
290RhabdomyolysisFAERS: 1US FAERS
291Saliva alteredFAERS: 1US FAERS
292ScreamingFAERS: 1US FAERS
293SepsisFAERS: 1US FAERS
294Septic ShockFAERS: 1US FAERS
295ShockFAERS: 1US FAERS
296Sinus TachycardiaFAERS: 1US FAERS
297Skin irritationFAERS: 1US FAERS
298Skin lacerationFAERS: 1US FAERS
299Skin lesionFAERS: 1US FAERS
300Skin tightnessFAERS: 1US FAERS
301Spinal column stenosisFAERS: 1US FAERS
302StridorFAERS: 1US FAERS
303Supraventricular tachycardiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
304Temperature intoleranceFAERS: 1US FAERS
305Terminal stateFAERS: 1US FAERS
306Therapeutic product effect decreasedFAERS: 1US FAERS
307Therapeutic response unexpectedFAERS: 1US FAERS
308Therapy partial responderFAERS: 1US FAERS
309Thoracic outlet surgeryFAERS: 1US FAERS
310Throat clearingFAERS: 1US FAERS
311ThrombocytopeniaFAERS: 1US FAERS
312ThrombosisFAERS: 1US FAERS
313Tooth ExtractionFAERS: 1US FAERS
314ToothacheFAERS: 1US FAERS
315TrismusFAERS: 1US FAERS
316UlcerFAERS: 1US FAERS
317Upper-airway cough syndromeFAERS: 1US FAERS
318Urinary IncontinenceFAERS: 1US FAERS
319Vaginal ProlapseFAERS: 1US FAERS
320Ventricular FibrillationFAERS: 1US FAERS
321Vitamin D DeficiencyFAERS: 1US FAERS
322Vitreous floatersFAERS: 1US FAERS
323YawningFAERS: 1US FAERS
324furuncleFAERS: 1US FAERS
325jaundiceFAERS: 1US FAERS
326Bulimia NervosaCanada Vigilance: 1Canada Vigilance
327EnteritisCanada Vigilance: 2Canada Vigilance
328LymphadenopathyCanada Vigilance: 1Canada Vigilance
329Night sweatsCanada Vigilance: 1Canada Vigilance
330Pain of skinCanada Vigilance: 1Canada Vigilance
331Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
332Rash erythematousCanada Vigilance: 1Canada Vigilance
333Skin reactionCanada Vigilance: 1Canada Vigilance
334Therapeutic product effect incompleteCanada Vigilance: 1Canada Vigilance
335Therapy non-responderCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.